Credit Suisse Ag T2 Biosystems, Inc. Transaction History

Credit Suisse Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$0.58 - $3.01 $10,151 - $52,684	-17,503 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.47 - $3.16 $25,729 - $55,309	17,503 New	17,503 $29,000
Q3 2017 Nov 14, 2017	SELL	$3.9 - $6.78 $163,355 - $283,987	-41,886 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	41,886	41,886 $134,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.